+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

From
From
From
Acetyl-CoA Carboxylase Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Acetyl-CoA Carboxylase Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
Bioengineered Protein Drugs Market Report 2026 - Product Thumbnail Image

Bioengineered Protein Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Hemophilia Market - Forecasts from 2023 to 2028 - Product Thumbnail Image

Hemophilia Market - Forecasts from 2023 to 2028

  • Report
  • December 2023
  • 143 Pages
  • Global
From
From
Bangladesh Pharmaceutical Market Future Opportunity Outlook 2025 - Product Thumbnail Image

Bangladesh Pharmaceutical Market Future Opportunity Outlook 2025

  • Report
  • July 2020
  • 222 Pages
  • Bangladesh
From
RNA Targeting Small Molecule Drug Discovery Market Report 2026 - Product Thumbnail Image

RNA Targeting Small Molecule Drug Discovery Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Loading Indicator